Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists

European Journal of Pharmacology

Volumn 386, Issue 2-3, 1999, Pages 155-163

  Vasiliadis, Helen Maria ^a,b   Élie, Robert ^a,b   Dewar, Karen M ^a,b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

6 Hydroxydopamine; Ligand binding autoradiography; Neostriatum; Substantia nigra

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; DESIPRAMINE; DIZOCILPINE; DOPAMINE RECEPTOR; EMONAPRIDE; GLUTAMATE RECEPTOR; MIANSERIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; PARGYLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; FEMALE; LIGAND BINDING; NEOSTRIATUM; NEUROTRANSMISSION; NEWBORN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZAMIDES; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; OXIDOPAMINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTORS, AMPA; RECEPTORS, DOPAMINE; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TRITIUM;

EID: 0343775815     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00770-0     Document Type: Article

References (43)

1. Blandini F., Porter R.H., Greenamyre J.T. Autoradiographic study of mitochondrial complex I and glutamate receptors in the basal ganglia of rats after unilateral subthalamic lesion. Neurosci. Lett. 186:1995;99-102.
2. Bouyer J.J., Park D.H., Joh T.H., Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminal in rat neostriatum. Brain Res. 302:1984;267-275.
3. Cha J.H., Makowiec R.L., Penney J.B., Young A.B. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography. Mol. Pharmacol. 41:1992;832-838.
4. Dall'Olio R., Facchinetti F., Contestabile A., Gandolfi O. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat. Neuroscience. 63:1994;451-455.
5. Dall'Olio R., Rimondini R., Gandolfi O. Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats. Psychopharmacology. 123:1996;187-190.
6. Draper N., Smith H. Applied Regression Analysis. 2nd edn. 1966;Wiley, New York.
7. Fenu S., Carta A., Morelli M. Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra. Synapse. 19:1995;233-240.
8. Fonnum F., Storm-Mathisen J., Divac I. Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience. 6:1981;863-873.
9. Gandolfi O., Dall'Olio R. Chronic treatment with MK-801 decreases D2 dopamine receptor function in rat striatum. Pharmacol. Biochem. Behav. 44:1993;683-687.
10. He Y., Lee T., Leong S.K. Effect of 6-OHDA injection on the AMPA glutamate receptor subunits in the substantia nigra of Sprague-Dawley rats. Neurosci. Lett. 241:1998;1-4.
11. Healy D.J., Meador-Woodruff J.H. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res. 708:1996;38-44.
12. Ingham C.A., Hood S.H., Taggart P., Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci. 18:1998;4732-4743.
13. Johnson K.B., Criswell H.E., Jensen K.F., Simson P.E., Mueller R.A., Breese G.R. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. J. Pharmacol. Exp. Ther. 262:1992;855-865.
14. Keefe K.A., Gerfen C.R. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367:1996;165-176.
15. Leslie C.A., Jung A., Bennett J.P. Potentiation of D2-dopamine receptor-mediated suppression of zif 268 by non-competitive NMDA receptor antagonists in reserpinized rats. Mol. Brain Res. 59:1998;40-49.
16. Löscher W., Annies R., Honack D. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J. Pharmacol. 242:1993;263-274.
17. Loschmann P.A., Kunow M., Wachtel H. Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease. J. Neural Transm., Suppl. 38:1992;55-64.
18. Loschmann P.A., Wullner U., Heneka M.T., Schulz J.B., Kunow M., Wachtel H., Klockgether T. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse. 26:1997;381-391.
19. 3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors. Neuroscience. 30:1989;87-94.
20. Mele A., Castellano C., Oliverio A. Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance. Psychopharmacology. 121:1995;401-405.
21. Micheletti G., Lannes B., Haby C., Borrelli E., Kempf E., Warter J.M., Zwiller J. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Mol. Brain Res. 14:1992;363-368.
22. Morelli M., Fenu S., Di Chiara G. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors. Neurochem. Int. 20:1992;261S-264S.
23. Murer M.G., Riquelme L.A., Tseng K.Y., Pazo J.H. Substantia nigra pars reticulata single unit activity in normal and 6-0HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse. 27:1997;278-293.
24. Nair V.D., Niznik H.B., Mishra R.K. NMDA and dopamine D2L receptor interaction in human neuroblastoma SH-SY5Y cells involves tyrosine kinase and phosphatase. NeuroReport. 7:1996;2937-2940.
25. Nakazato E., Ohno M., Watanabe S. MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum. Eur. J. Pharmacol. 342:1998;209-212.
26. Oh J.D., Vaughan C.L., Chase T.N. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res. 821:1999;433-442.
27. Overton P., Clark D. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse. 10:1992;131-140.
28. Porter R.H., Greene J.G., Higgins D.S., Greenamyre J.T. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 11:1994;7192-7199.
29. Qin Z.H., Zhou L.W., Weiss B. D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors. Neuroscience. 60:1994;97-114.
30. Quirion R., Bayorh M.A., Zerbe R.L., Pert C.B. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacol. Biochem. Behav. 4:1982;699-702.
31. Radja F., El Mansari M., Soghomonian J.-J., Dewar K.M., Ferron A., Reader T.A., Descarries L. Changes in D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience. 57:1993;635-648.
32. Reader T.A., Dewar K.M. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem. Int. 34:1999;1-21.
33. Rosales M.G., Flores G., Hernandez S., Martinez-Fong D., Aceves J. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res. 645:1994;335-337.
34. Rosales M.G., Martinez-Fong D., Morales R., Nunez A., Flores G., Gongora-Alfaro J.L., Floran B., Aceves J. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience. 80:1997;803-810.
35. Snyder G.L., Fienberg A.A., Huganir R.L., Greengardm P.J. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18:1998;10297-10303.
36. Stachowiak M.K., Bruno J.P., Snyder A.M., Stricker E.M., Zigmond M.J. Apparent sprouting of striatal dopaminergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291:1984;164-167.
37. Tarazi F.I., Florijn W.J., Creese I. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology. 128:1996;371-379.
38. Vila M., Marin C., Ruberg M., Jimenez A., Raisman-Vozari R., Agid Y., Tolosa E., Hirsch E.C. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. J. Neurochem. 73:1999;344-352.
39. Wachtel H., Kunow M., Loschmann P.A. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neurosci. Lett. 142:1992;179-182.
40. Wilson C.J., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular injection of horseradish peroxidase. J. Comp. Neurol. 194:1980;599-615.
41. Wedzony K., Klimek V., Golembiowska K. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res. 622:1993;325-329.
42. Wedzony K., Czyrak A., Mackowiak M., Fijal K. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;517-527.
43. Wüllner U., Testa C.M., Catania M.V., Young A.B., Penney J.B. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res. 645:1994;98-102.